Home » Cancer, vaccines by 2030 thanks to mRna

Cancer, vaccines by 2030 thanks to mRna

by admin

Moderna’s announcement: by 2030 we could have vaccines against the diseases that are the leading cause of death. All thanks to the mRna, already decisive against Covid

The world‘s first vaccines against cancer, cardiovascular and autoimmune diseases could arrive by 2030. The announcement of an upcoming revolution in medicine that will allow millions of lives to be saved thanks to personalized vaccines came from the American company Moderna, according to the Guardian. The experience gained with the anti-Covid vaccines, Modern points out, has allowed studies on anti-cancer vaccines to speed up research, so much so that the equivalent of 15 years of progress has been achieved in just 12-18 months.

According to Dr Paul Burton, Moderna’s medical director, the company will be able to offer these vaccines in just five years. “The vaccines that will arrive – explains Burton – will be very effective, and will save hundreds of thousands if not millions of lives. I believe we will be able to offer personalized anti-cancer vaccines against many different types of tumors to the world population”.

How will they work

Cancer vaccines will work like this: As a first step, a biopsy on cancer cells will identify mutations not present in healthy cells. Subsequently, an algorithm will identify which mutations are causing tumor growth and are able to activate the immune system. A molecule of messenger RNA (mRNA) will then be created with instructions for producing the antigens that will cause an immune response. The mRNA, once injected, will result in parts of proteins identical to those found in cancer cells. Immune cells encounter them and destroy cancer cells carrying the same proteins.

See also  Disneyland's Splash Mountain will be Tiana's Estuary Adventure in 2024 - Gamereactor

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy